Product How it works Pricing Blog FAQ About Contact
Arrowhead Pharmaceuticals

Arrowhead Pharmaceuticals (NASDAQ: ARWR) revenue

Arrowhead Pharmaceuticals reported revenue of $829.4m for fiscal 2025, 23,258.2% more than in fiscal 2024 ($3.6m). Since fiscal 2016 its revenue has grown by 523,763.0%, an average growth of 159.0% a year.

Fiscal 2025 is the highest of the 10 fiscal years on record for Arrowhead Pharmaceuticals. The biggest drop was in fiscal 2024, −98.5%.

Revenue, in millions of US dollars0.2201631.4201716.12018168.8201988.02020138.32021243.22022240.720233.62024829.42025
Embed this chart

Copy this code into your website or blog. The chart updates with each new annual report.

Revenue by fiscal year

Fiscal yearRevenueChangeOperating profitOperating margin
2025$829.4m+23,258.2%$98.3m11.9%
2024$3.6m−98.5%−$601.1m−16,927.1%
2023$240.7m−1.0%−$205.0m−85.2%
2022$243.2m+75.9%−$178.5m−73.4%
2021$138.3m+57.2%−$149.0m−107.8%
2020$88.0m−47.9%−$93.2m−105.9%
2019$168.8m+945.7%$61.2m36.3%
2018$16.1m−48.6%−$55.9m−346.5%
2017$31.4m+19,736.5%−$37.0m−117.8%
2016$0.2m—−$81.7m−51,627.1%

The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.

Arrowhead Pharmaceuticals revenue compared with its sector

By revenue for its latest fiscal year, Arrowhead Pharmaceuticals ranks 164th of the 422 US health care companies with a page on Celsmar. The sector median grew 11.7% in its latest fiscal year; Arrowhead Pharmaceuticals, 23,258.2%.

RankCompanyRevenueRevenue growth
162ndHarmony Biosciences$868.5m21.5%
163rdVarex Imaging$844.6m4.1%
164thArrowhead Pharmaceuticals$829.4m23,258.2%
165thMyriad Genetics$824.5m−1.6%
166thOrthofix Medical$822.3m2.9%

Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.

Questions about the revenue of Arrowhead Pharmaceuticals

How much revenue did Arrowhead Pharmaceuticals make in fiscal 2025?
Arrowhead Pharmaceuticals reported revenue of $829.4m for fiscal 2025, compared with $3.6m in fiscal 2024.
How much has the revenue of Arrowhead Pharmaceuticals grown?
Between fiscal 2016 and fiscal 2025 it went from $0.2m to $829.4m: 523,763.0% more, an average growth of 159.0% a year.
What was the best year for revenue at Arrowhead Pharmaceuticals?
Of its last 10 fiscal years, fiscal 2025, with $829.4m.
Where does Arrowhead Pharmaceuticals rank in its sector by revenue?
It ranks 164th of the 422 US health care companies with a page on Celsmar, by revenue for its latest fiscal year.
Where do the figures for Arrowhead Pharmaceuticals come from?
From the annual report (Form 10-K) that Arrowhead Pharmaceuticals files with the SEC, the US securities regulator. Each fiscal year links to its filing.

Where each figure comes from

From the annual report (Form 10-K) that Arrowhead Pharmaceuticals files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017 · 2016. More on Arrowhead Pharmaceuticals: the Arrowhead Pharmaceuticals page · annual accounts · net income · insider transactions.

Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.